Beta BionicsBBNX

那斯達克 · USD
19.05
-0.43
(-2.21%)
收盤 08/22 03:59 (UTC+8)
08/22 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.13
  • 0.15
  • 0.17
  • 0.20
  • 0.18
  • 0.23
  • 0.27
  • 0.32
  • 0.28
  • 0.32
icon
  • 54.89
  • 16.34
  • 11.03
  • 22.36
  • -
  • 31.74
  • 17.28
  • 17.86
  • -13.99
  • 15.88
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
32,013
27,626
32,121
27,253
23,238
17,639
20,440
16,705
15,046
12,933
營業成本
13,11111,18913,17712,13410,7358,6688,7517,7916,9625,732
營業毛利
18,902
16,437
18,944
15,119
12,503
8,971
11,689
8,914
8,084
7,201
營業費用
44,48040,70835,06832,16232,375-24,72619,89119,86816,654
研發費用
10,24010,35610,1318,1958,8737,5909,2145,1416,3505,479
推銷及管理費用
34,24030,35224,93723,96723,50220,02315,51214,75013,51811,175
非經常性項目費用
----------
其他營業費用
----------
營業利益
-25,578
-24,271
-16,124
-17,043
-19,872
-18,642
-13,037
-10,977
-11,784
-9,453
其他收入及費用
2,1752,3762,6582,8343,003-10,014-5,071---
利息費用
----------
稅前純益
-23,403
-21,895
-13,466
-14,209
-16,869
-28,656
-18,108
-9,736
-14,463
-12,449
所得稅
----------
稅後純益
-23,403
-21,895
-13,466
-14,209
-16,869
-28,656
-18,108
-9,736
-14,463
-12,449
基本每股稅後盈餘(元)
-0.53-0.49-0.30-0.33-0.39-0.93-0.42-0.23-0.34-0.41
稀釋每股稅後盈餘(元)
-0.53-0.49-0.29-0.29-0.30-0.93-2.74-0.23-0.34-0.41
基本平均股數(千股)
44545.0044436.0044194.0043634.0043390.0030714.0042859.0042859.0042859.0030495.00
稀釋平均股數(千股)
44545.0044436.0044194.0043634.0043390.0030714.0042859.0042859.0042859.0030495.00
還原基本每股稅後盈餘(元)
-0.53-0.49-0.30-0.33-0.39-0.93-0.42-0.23-0.34-0.41
還原稀釋每股稅後盈餘(元)
-0.53-0.49-0.29-0.29-0.30-0.93-2.74-0.23-0.34-0.41
還原基本平均股數(千股)
44,54544,43644,19443,63443,39030,71442,85942,85942,85930,495
還原稀釋平均股數(千股)
44,54544,43644,19443,63443,39030,71442,85942,85942,85930,495
EBITDA(千元)
-22,190-20,822-12,493-13,825-17,030-28,968-18,198-9,121-13,887-11,886

大家都在看

HOT